Subscribe to Updates in Consumer Goods & Services

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Weight Management Experts

Articles with lock require a subscription to GLG News | Request a free trial
Dirk AschmoneitOctober 4, 2007
Nutrisystem hits plateau. Is NTRI the next diet fad after Atkins?
Analysis of: NutriSystem, Inc. Reports Preliminary Third Quarter 2007 Results, Authorizes Additional Share Repurchases and Establishes $200 Million Credit Facility | biz.yahoo.com
Author: Dirk Aschmoneit, Director of Food & Retail Marketing, Jenny Craig, Inc.
Evaluation of NTRI Q3 performance: Q3 underperformance is not an indicator of a fad diet. Competition and lack of new campaign are primary drivers of recent performance. However, this might be an early indicator that NTRI is done with their steep growth phase and enters into the maturity phase with...
Dirk AschmoneitJune 15, 2007
Topline review of Alli
Analysis of: Over-The-Counter Weight Loss Drug Approved | abclocal.go.com
Author: Dirk Aschmoneit, Director of Food & Retail Marketing, Jenny Craig, Inc.
Glaxo Smith Kline is trying to reposition Xenical Here is a quick review of the past.  It should be a solid indicator for the new initiative. Historical evolution of Alli: 1] GSK sales for Xenical $115.6 mil in 2004, down from $154.5 mil in 2002 2] Gastrointestinal side effects caused slow down...
Dirk AschmoneitFebruary 2, 2007
Reality Check for Nutrisystem
Analysis of: Nutrisystem Shares Slide on Target Cut | biz.yahoo.com
Author: Dirk Aschmoneit, Director of Food & Retail Marketing, Jenny Craig, Inc.
 After 3 years of impressive growth it might be time for a reality check for Nutrisystem (NTRI). The stock got “pounded” this week after NTRI issued a lower than expected guidance for Q107 and a Citigroup analyst lowered his target price by $13 (from $105 to $92).  Is it time for bypass surgery...

Page : 11 to 3 of 3

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-04T13:45:22.160